Radomir Zivadinovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Radomir Zivadinovic has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Petric
Ginekološko-akušerska klinika, Niš
13 shared publications - Dane Krtinić
Clinic of Oncology, University Clinical Centre of Nis, 18000 Nis, Serbia
4 shared publications I Todorovska
Clin Ctr, Dept Pharmacol & Toxicol, Clin Oncol, Nish, Serbia
4 shared publications- Predrag Vukomanovic
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Nis, 18000 Nis, Serbia
4 shared publications Vekoslav Lilic
Clinical Center, Clinic of Gynecology and Obstetrics, Niš
4 shared publicationsBiljana Djordjevic
Clinical Center, Institute for Pathology, Niš
3 shared publications
Latest Publications
- 1 January 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Glasnik javnog zdravlja
- Vol. 96 (3) , 333-341
Cervical cancer screening: Past, present and outlook
Cervical cancer is the fourth most common carcinoma in women globally, following breast, lung and colon cancer. Primary prevention (vaccination) and secondary prevention (organised screening) in developed countries have made a significant difference in the structure of morbidity, as well as mortality from this disease, compared to undeveloped countries. The primary objective of cervical cancer screening is identification of abnormal epithelial cells that are likely to progress into invasive carcinoma (CIN II + and AIS) and that require surgical treatment, which reduces cervical cancer incidence and mortality. Secondary objective of screening is diagnosing early stages of invasive carcinoma (MIC) which also decreases cervical cancer morbidity and mortality. Cervical cancer screening strategy differs in different parts of the world and needs to be adapted to the methods that are available and reliable in the given country, and that allow for the best possible organisational arrangements and development of the infrastructure for cancer screening implementation and quality assurance, in line with specific human and financial resources available to the country
- 1 January 2022
- Published by Centre for Evaluation in Education and Science (CEON/CEES) in Glasnik javnog zdravlja
- Vol. 96 (3) , 333-341
Cervical cancer screening: Past, present and outlook
Cervical cancer is the fourth most common carcinoma in women globally, following breast, lung and colon cancer. Primary prevention (vaccination) and secondary prevention (organised screening) in developed countries have made a significant difference in the structure of morbidity, as well as mortality from this disease, compared to undeveloped countries. The primary objective of cervical cancer screening is identification of abnormal epithelial cells that are likely to progress into invasive carcinoma (CIN II + and AIS) and that require surgical treatment, which reduces cervical cancer incidence and mortality. Secondary objective of screening is diagnosing early stages of invasive carcinoma (MIC) which also decreases cervical cancer morbidity and mortality. Cervical cancer screening strategy differs in different parts of the world and needs to be adapted to the methods that are available and reliable in the given country, and that allow for the best possible organisational arrangements and development of the infrastructure for cancer screening implementation and quality assurance, in line with specific human and financial resources available to the country
- Open Access
- 15 December 2021
- Published by Medical Faculty, University in Nis in Acta Medica Medianae
- Vol. 60 (4) , 16-22
FEATURES OF ENDOCERVICAL ADENOCARCINOMA IN RELATION TO SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX
- 15 December 2021
- Published by Medical Faculty, University in Nis in Acta Medica Medianae
- Vol. 60 (4) , 16-22
Open AccessFEATURES OF ENDOCERVICAL ADENOCARCINOMA IN RELATION TO SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CARCINOMA OF THE UTERINE CERVIX
- Open Access
Knowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia
Background and objectives: Persistent infection with carcinogenic human papillomavirus (HPV) is the leading cause of cervical cancer. The study explored students’ knowledge about cervical cancer and awareness of human papillomavirus and the HPV vaccine. Materials and Methods: A questionnaire-based survey was carried out among 1616 first-year female college students at the University of Niš. It examined socio-demographic characteristics, measured the score of knowledge about cervical cancer, assessed awareness regarding HPV and the HPV vaccine and inquired about the source of information about cervical cancer and HPV. Results: The average cervical cancer knowledge score was 16.35 ± 7.92 (min 0, max 30), with medical professional education, parents’ education level, place of residence and relationship status having significant effects on the score. The awareness about HPV and the HPV vaccine was low, with only 14.2% of students having heard about both HPV and its vaccine. The most commonly reported sources of information were the media, while the most competent one was organized health education. Conclusions: Health promotion campaigns and educational programs are necessary in order to reduce cervical cancer burden and should be directed particularly towards those who have demonstrated low cervical cancer knowledge and low awareness regarding HPV and its vaccine.
Open AccessKnowledge about Cervical Cancer and Awareness of Human Papillomavirus (HPV) and HPV Vaccine among Female Students from Serbia
Background and objectives: Persistent infection with carcinogenic human papillomavirus (HPV) is the leading cause of cervical cancer. The study explored students’ knowledge about cervical cancer and awareness of human papillomavirus and the HPV vaccine. Materials and Methods: A questionnaire-based survey was carried out among 1616 first-year female college students at the University of Niš. It examined socio-demographic characteristics, measured the score of knowledge about cervical cancer, assessed awareness regarding HPV and the HPV vaccine and inquired about the source of information about cervical cancer and HPV. Results: The average cervical cancer knowledge score was 16.35 ± 7.92 (min 0, max 30), with medical professional education, parents’ education level, place of residence and relationship status having significant effects on the score. The awareness about HPV and the HPV vaccine was low, with only 14.2% of students having heard about both HPV and its vaccine. The most commonly reported sources of information were the media, while the most competent one was organized health education. Conclusions: Health promotion campaigns and educational programs are necessary in order to reduce cervical cancer burden and should be directed particularly towards those who have demonstrated low cervical cancer knowledge and low awareness regarding HPV and its vaccine.
- 2 January 2019
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 38 (1) , 52-57
T lymphocytes in the third trimester decidua in preeclampsia
The aim of study was to conduct immunohistochemical quantification of CD3+ and CD8+ decidual lymphocytes in preeclampsia. A study group included 30 cases of preeclampsia and a control group included 20 healthy pregnant women, all delivered by Cesarean section. Samples of placental bed were analyzed after immunohistochemical staining of CD45+, CD3+ and CD8+ cells. The group with preeclampsia included a significantly higher number of CD3+ (p < 0.01) and CD8+ (p < 0.05) T lymphocytes. It is certain that thebalance dysregulation of T cell of the immune milieu of deciduais of importance in etiopathogenesis and manifestations of preeclampsia.
- 2 January 2019
- Published by Taylor & Francis in Hypertension in Pregnancy
- Vol. 38 (1) , 52-57
T lymphocytes in the third trimester decidua in preeclampsia
The aim of study was to conduct immunohistochemical quantification of CD3+ and CD8+ decidual lymphocytes in preeclampsia. A study group included 30 cases of preeclampsia and a control group included 20 healthy pregnant women, all delivered by Cesarean section. Samples of placental bed were analyzed after immunohistochemical staining of CD45+, CD3+ and CD8+ cells. The group with preeclampsia included a significantly higher number of CD3+ (p < 0.01) and CD8+ (p < 0.05) T lymphocytes. It is certain that thebalance dysregulation of T cell of the immune milieu of deciduais of importance in etiopathogenesis and manifestations of preeclampsia.
- Open Access
- 1 September 2018
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 146 (9-10) , 588-592
Unruptured tubal pregnancy in early second trimester
- 1 September 2018
- Published by National Library of Serbia in Srpski arhiv za celokupno lekarstvo
- Vol. 146 (9-10) , 588-592
Open AccessUnruptured tubal pregnancy in early second trimester
- 1 August 2018
- Vol. 22 (16) , 5149-5155
Significance of the Ki-67 proliferation index in the assessment of the therapeutic response to cisplatin-based chemotherapy in patients with advanced cervical cancer
OBJECTIVE: The purposes of this study were to examine the therapeutic response of advanced cervical cancerto Ki-67 proliferative index (Ki-67 PI) dependent cisplatin chemotherapy, and to determine KI-67 PI referential value that is expected to provides satisfactory therapeutic response of cervical cancer to cisplatin chemotherapy. PATIENTS AND METHODS: This prospective study enrolled 59 patients treated for cervical cancer at Clinic for Oncology, Clinical Center Nis, Serbia. According to the obtained Ki-67 PI values, patients were divided into three groups, and all the patients received the same cytostatic, cisplatin. Therapeutic response to chemotherapy was evaluated in relation to disease progression presence or absence and progression-free survival after a year follow-up since the first chemotherapy. RESULTS: Survival rate increases with an increase of Ki-67 PI by Kaplan-Meier survival analysis, meaning that survival rate is statistically significantly shorter in the group of patients with Ki-67 PI < 40% in comparison to patients from other two groups (p=0.010). Mann-Whitney test confirmed a statistically significant increase in survival rate among the groups of patients formed according to Ki-67 PI (p= 60%), moderate KI-67 PI (40-60%), and low Ki-67 PI (>= 40%).
- 1 August 2018
- Vol. 22 (16) , 5149-5155
Significance of the Ki-67 proliferation index in the assessment of the therapeutic response to cisplatin-based chemotherapy in patients with advanced cervical cancer
OBJECTIVE: The purposes of this study were to examine the therapeutic response of advanced cervical cancerto Ki-67 proliferative index (Ki-67 PI) dependent cisplatin chemotherapy, and to determine KI-67 PI referential value that is expected to provides satisfactory therapeutic response of cervical cancer to cisplatin chemotherapy. PATIENTS AND METHODS: This prospective study enrolled 59 patients treated for cervical cancer at Clinic for Oncology, Clinical Center Nis, Serbia. According to the obtained Ki-67 PI values, patients were divided into three groups, and all the patients received the same cytostatic, cisplatin. Therapeutic response to chemotherapy was evaluated in relation to disease progression presence or absence and progression-free survival after a year follow-up since the first chemotherapy. RESULTS: Survival rate increases with an increase of Ki-67 PI by Kaplan-Meier survival analysis, meaning that survival rate is statistically significantly shorter in the group of patients with Ki-67 PI < 40% in comparison to patients from other two groups (p=0.010). Mann-Whitney test confirmed a statistically significant increase in survival rate among the groups of patients formed according to Ki-67 PI (p= 60%), moderate KI-67 PI (40-60%), and low Ki-67 PI (>= 40%).
- Open Access
- 29 November 2017
- Published by IntechOpen
Ascitic Fluid in Ovarian Carcinoma – From Pathophysiology to the Treatment
Due to low symptomatology, a lack of screening, and relatively complicated diagnostic procedures of ovarian carcinoma, more and more women are believed to visit their doctors in advanced stage of the disease, complicated with ascitic fluid. There is an increasing evidence that peritoneal cytology is a subjective assessment with certain percentage of false-positive and false-negative results that may cause application of unnecessary chemotherapy or nonapplication of necessary chemotherapy. Maximal cytoreductive surgery followed by intraperitoneal or systemic chemotherapy remains to be the gold standard in preventing ascites. Ascites is not only a symptom of a disease, but a specific microenvironment for formation and mediation of protumorigenic signals that control ovarian cancer progression, proliferation, invasion, anti-apoptosis, chemoresistance and tumor heterogeneity. Acellular cytokines and immunological factors influence ovarian cancer progression and its ability to prevent immune responses of the body and tumor reaction to chemotherapy. Ascites contributes to disease dissemination, changing its course and final outcomes. Management of patients with ascites and ovarian carcinoma is complex and often the goal of the treatment is to target palliative procedures. Multidisciplinary approach is necessary in the management of these patients. Further investigations of new drugs and immunomodulators are needed aiming at prolonged periods between relapses.
- 29 November 2017
- Published by IntechOpen
Open AccessAscitic Fluid in Ovarian Carcinoma – From Pathophysiology to the Treatment
Due to low symptomatology, a lack of screening, and relatively complicated diagnostic procedures of ovarian carcinoma, more and more women are believed to visit their doctors in advanced stage of the disease, complicated with ascitic fluid. There is an increasing evidence that peritoneal cytology is a subjective assessment with certain percentage of false-positive and false-negative results that may cause application of unnecessary chemotherapy or nonapplication of necessary chemotherapy. Maximal cytoreductive surgery followed by intraperitoneal or systemic chemotherapy remains to be the gold standard in preventing ascites. Ascites is not only a symptom of a disease, but a specific microenvironment for formation and mediation of protumorigenic signals that control ovarian cancer progression, proliferation, invasion, anti-apoptosis, chemoresistance and tumor heterogeneity. Acellular cytokines and immunological factors influence ovarian cancer progression and its ability to prevent immune responses of the body and tumor reaction to chemotherapy. Ascites contributes to disease dissemination, changing its course and final outcomes. Management of patients with ascites and ovarian carcinoma is complex and often the goal of the treatment is to target palliative procedures. Multidisciplinary approach is necessary in the management of these patients. Further investigations of new drugs and immunomodulators are needed aiming at prolonged periods between relapses.
- 13 October 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (12) , 1870-1879
Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women
Aim: This study is a comparison of human epididymis protein 4 (HE4) with cancer antigen 125 (CA125), using the Risk of Ovarian Malignancy Algorithm (ROMA), Copenhagen Index (CPH‐I), Risk of Malignancy Index (RMI) and Morphology Index (MI) to differentiate ovarian endometriosis from epithelial ovarian cancer (EOC) in premenopausal women.Methods: The study was performed at the University Clinic of Obstetrics and Gynecology in Skopje. One hundred and sixty‐four premenopausal patients were divided into three study groups, including ovarian endometriosis (37), other benign pelvic masses (57) and EOCs (11), and a control group (59). After ultrasonography, all subjects underwent blood sampling. Surgery and histological verification was performed. Pelvic masses were classified based on histological findings. Mann–Whitney, receiver operating characteristic‐area under the curve (AUC), sensitivity, specificity and Kruskal–Wallis tests were used for statistical analysis. The level of significance α was set at 5%.Results: For each of the tested markers, sensitivity, specificity and accuracy to distinguish ovarian endometriosis from EOC were as follows: HE4 (81.82%, 100%, 95.83%); CA125 (81.82%, 48.65%, 56.25%); ROMA (90.91%, 83.78%, 85.42%); CPH‐I (81.82%, 97.30%, 93.75%); RMI (90.91%, 35.14%, 47.92%); and MI (100%, 75.68%, 81.25%), respectively. The AUC for ovarian endometriosis compared to EOC for tested markers was as follows: HE4 (AUC = 0.934), CA125 (AUC = 0.821), ROMA (AUC = 0.929), CPH‐I (AUC = 0.924) and RMI (AUC = 0.880), respectively.Conclusion: HE4 and CPH‐I perform best to discriminate ovarian endometriosis from EOC in premenopausal women. MI has maximal sensitivity to detect EOC.
- 13 October 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (12) , 1870-1879
Diagnostic performance of human epididymis protein 4 compared to a combination of biophysical and biochemical markers to differentiate ovarian endometriosis from epithelial ovarian cancer in premenopausal women
Aim: This study is a comparison of human epididymis protein 4 (HE4) with cancer antigen 125 (CA125), using the Risk of Ovarian Malignancy Algorithm (ROMA), Copenhagen Index (CPH‐I), Risk of Malignancy Index (RMI) and Morphology Index (MI) to differentiate ovarian endometriosis from epithelial ovarian cancer (EOC) in premenopausal women.Methods: The study was performed at the University Clinic of Obstetrics and Gynecology in Skopje. One hundred and sixty‐four premenopausal patients were divided into three study groups, including ovarian endometriosis (37), other benign pelvic masses (57) and EOCs (11), and a control group (59). After ultrasonography, all subjects underwent blood sampling. Surgery and histological verification was performed. Pelvic masses were classified based on histological findings. Mann–Whitney, receiver operating characteristic‐area under the curve (AUC), sensitivity, specificity and Kruskal–Wallis tests were used for statistical analysis. The level of significance α was set at 5%.Results: For each of the tested markers, sensitivity, specificity and accuracy to distinguish ovarian endometriosis from EOC were as follows: HE4 (81.82%, 100%, 95.83%); CA125 (81.82%, 48.65%, 56.25%); ROMA (90.91%, 83.78%, 85.42%); CPH‐I (81.82%, 97.30%, 93.75%); RMI (90.91%, 35.14%, 47.92%); and MI (100%, 75.68%, 81.25%), respectively. The AUC for ovarian endometriosis compared to EOC for tested markers was as follows: HE4 (AUC = 0.934), CA125 (AUC = 0.821), ROMA (AUC = 0.929), CPH‐I (AUC = 0.924) and RMI (AUC = 0.880), respectively.Conclusion: HE4 and CPH‐I perform best to discriminate ovarian endometriosis from EOC in premenopausal women. MI has maximal sensitivity to detect EOC.
- 15 September 2016
- Published by Medical Faculty, University in Nis in Acta Medica Medianae
- Vol. 55 (3) , 85-91
HIV AND AIDS IN PREGNANCY
- 15 September 2016
- Published by Medical Faculty, University in Nis in Acta Medica Medianae
- Vol. 55 (3) , 85-91
HIV AND AIDS IN PREGNANCY
- 26 July 2016
- Published by West Indian Medical Journal in West Indian Medical Journal
- Vol. 66 (1) , 83-87
Analysis of the Menstrual Cycle Variabilities of the Human Epididymis Protein 4
- 26 July 2016
- Published by West Indian Medical Journal in West Indian Medical Journal
- Vol. 66 (1) , 83-87
Analysis of the Menstrual Cycle Variabilities of the Human Epididymis Protein 4